SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-117703
Filing Date
2020-10-23
Accepted
2020-10-23 16:02:35
Documents
1
Period of Report
2020-10-21

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 2998
  Complete submission text file 0001104659-20-117703.txt   4379
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O HOOKIPA PHARMA INC. 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address
van de Winkel Jan (Reporting) CIK: 0001767091 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38869 | Film No.: 201257771